Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

03.04.2020 back forward

Supply Bottleneck for Pneumococcal Vaccines

Vaccine syringes (Source: Sydney NSW / Shutterstock)

The pandemic leads to a significant increase in demand for pneumococcal vaccines. Via its supply bottleneck management system, the Paul-Ehrlich-Institut identifies the shortages of these vaccines. The official declaration of a supply shortage leads, in accordance with Section 79 of the Medicinal Products Act, to an exceptional authorisation enabling the import of the shortfall in vaccine doses. From 3 April 2020 onwards, additional doses of the pneumococcal vaccine Pneumovax 23 imported from Japan are available, as well as imported doses of Prevenar 13 from 28 April 2020.

Communication Creates Transparency